Lenalidomide : A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:96 |
|---|---|
| Enthalten in: |
American journal of hematology - 96(2021), 6 vom: 01. Juni, Seite 749-754 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Loscocco, Giuseppe G [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 24.06.2021 Date Revised 24.06.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/ajh.26153 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322758262 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322758262 | ||
| 003 | DE-627 | ||
| 005 | 20231225182721.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ajh.26153 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1075.xml |
| 035 | |a (DE-627)NLM322758262 | ||
| 035 | |a (NLM)33719069 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Loscocco, Giuseppe G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lenalidomide |b A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.06.2021 | ||
| 500 | |a Date Revised 24.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ET | |
| 650 | 4 | |a PV | |
| 650 | 4 | |a multiple myeloma | |
| 650 | 4 | |a myelofibrosis | |
| 650 | 4 | |a myeloproliferative neoplasms | |
| 650 | 7 | |a CALR protein, human |2 NLM | |
| 650 | 7 | |a Calreticulin |2 NLM | |
| 650 | 7 | |a Dexamethasone |2 NLM | |
| 650 | 7 | |a 7S5I7G3JQL |2 NLM | |
| 650 | 7 | |a Lenalidomide |2 NLM | |
| 650 | 7 | |a F0P408N6V4 |2 NLM | |
| 650 | 7 | |a Aspirin |2 NLM | |
| 650 | 7 | |a R16CO5Y76E |2 NLM | |
| 650 | 7 | |a Hydroxyurea |2 NLM | |
| 650 | 7 | |a X6Q56QN5QC |2 NLM | |
| 700 | 1 | |a Antonioli, Elisabetta |e verfasserin |4 aut | |
| 700 | 1 | |a Romano, Ilaria |e verfasserin |4 aut | |
| 700 | 1 | |a Vergoni, Federica |e verfasserin |4 aut | |
| 700 | 1 | |a Rotunno, Giada |e verfasserin |4 aut | |
| 700 | 1 | |a Mannelli, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Guglielmelli, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Vannucchi, Alessandro M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of hematology |d 1993 |g 96(2021), 6 vom: 01. Juni, Seite 749-754 |w (DE-627)NLM000124354 |x 1096-8652 |7 nnns |
| 773 | 1 | 8 | |g volume:96 |g year:2021 |g number:6 |g day:01 |g month:06 |g pages:749-754 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ajh.26153 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 96 |j 2021 |e 6 |b 01 |c 06 |h 749-754 | ||